Trials / Conditions / Severe Congenital Neutropenia

Severe Congenital Neutropenia

12 registered clinical trials studyying Severe Congenital Neutropenia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Baby Detect : Genomic Newborn Screening NCT05687474	Centre Hospitalier Universitaire de Liege	—
Not Yet Recruiting	Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia NCT04844177	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 2
Recruiting	Investigation of the Genetics of Hematologic Diseases NCT02720679	St. Jude Children's Research Hospital	—
Terminated	Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies NCT02179359	Masonic Cancer Center, University of Minnesota	N/A
Completed	Bone Marrow Transplant With Abatacept for Non-Malignant Diseases NCT01917708	Emory University	Phase 1
Active Not Recruiting	CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation NCT01966367	Diane George	Phase 1 / Phase 2
Completed	Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem NCT01529827	Roswell Park Cancer Institute	Phase 2
Terminated	Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation NCT01319851	Emory University	N/A
Completed	Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Fai NCT00295971	University of California, San Francisco	Phase 1
Completed	Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With NCT00301834	University of California, San Francisco	Phase 2
Completed	Stem Cell Transplant for Hemoglobinopathy NCT00176852	Masonic Cancer Center, University of Minnesota	Phase 2 / Phase 3
Completed	Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young P NCT00305708	University of California, San Francisco	Phase 1 / Phase 2